Physician profile
Joseph B Thurman
NPI 1669734323
$319.99
in general payments reported to CMS, 2019-2025
10 companies · $91.38 in 2025
The $91.38 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $70.94 · 2023: $76.39 · 2024: $81.28 · 2025: $91.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $65.00 | 2023-2024 | Ligasure, Dextile |
| Takeda Pharmaceuticals U.S.A., INC. | $63.23 | 2023-2024 | Gattex |
| W. L. Gore & Associates, INC. | $49.11 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Daiichi Sankyo INC. | $40.34 | 2022 | |
| Solventum Corporation | $22.05 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Teleflex LLC | $20.22 | 2025 | Deknatel |
| Braintree Laboratories, INC. | $16.45 | 2022 | |
| Stryker Corporation | $15.56 | 2024 | Eikon Lt Adapt Smoke Evacuation, Eikon |
| Bard Peripheral Vascular, INC. | $14.15 | 2022 | |
| Currax Pharmaceuticals LLC | $13.88 | 2023 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Thurman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.